Biotech stocks returned up to 36% in 2025, while longevity investing hit $8.5B in funding. Here’s the data individual investors should know.

Viral vector gene therapy represents a rapidly advancing field at the intersection of molecular medicine, biotechnology, and clinical translation. Viral ...

A London-based biotech start-up is accelerating its growth after securing investment to advance artificial intelligence-driven drug discovery technology. Ternary Therapeutics has… | Health | London | ...

A growing field of research suggests that some medical treatments, such as cancer therapy or vaccines, might be more ...

A new approach that integrates room for debate and collaboration with effective communication strategies can enable more ...

In the realm of cellular biology, programmed cell death (PCD) stands as a pivotal process governing the elimination of cells, thereby maintaining tissue homeostasis and ensuring an organism's health ...

Lawmakers are again considering expanding the state’s R&D tax credit to small businesses. Advocates are hopeful it will pass this session.

New research-use-only materials platform reinforces verified researcher access, documentation standards, and laboratory handling protocols Sebastopol, California— February 26, 2026 — BiotechLabzSupply ...

President Donald Trump will deliver the State of the Union address on Feb. 24. It will be his second speech to a joint session of Congress since returning to office. Ahead of the address, here’s a ...

Biotech stock Grail Inc (NASDAQ:GRAL) is taking a nosedive today, brushing off better-than-expected fourth-quarter results after the company's three-year cancer screening trial failed to meet its main ...

Ruminant BioTech—a New Zealand-based startup with “slow-release” livestock methane reduction tech for pasture-based cattle—has launched a CAD$7.6 million ($5.6 million) research program to validate ...